RFC
XLRN

Russell Frank Company’s Acceleron Pharma XLRN Stock Holding History

Russell Frank Company’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$80K Buy
+3,022
New +$87.9K ﹤0.01% 2810
2014
Q1 		– Sell
-18,345
Closed -$840K – 2899
2013
Q4 		$840K Buy
+18,345
New +$443K ﹤0.01% 2147

Other funds holding XLRN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
PVMCI
Polaris Venture Management Co IV Boston, Massachusetts $62.4M AUM 33.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Russell Frank Company's XLRN Position: Q1 2016 in Review

Russell Frank Company opened a new position in Acceleron Pharma (XLRN) in Q1 2016: 3,022 shares worth $80K. The stake represents ﹤0.01% of the portfolio and ranks #2810 among its holdings. This is a return to the name: Russell Frank Company previously reported a position in XLRN as recently as Q4 2013.

Russell Frank Company first reported a position in XLRN in Q4 2013 and has held it in 2 quarters since. The position peaked at $840K in Q4 2013. 128 funds tracked by Wall St. Rank hold XLRN as of Q1 2016.

  • Russell Frank Company held 3,022 shares of Acceleron Pharma worth $80K as of Q1 2016.
  • Acceleron Pharma was a new Russell Frank Company position in Q1 2016.
  • Acceleron Pharma made up ﹤0.01% of Russell Frank Company's portfolio in Q1 2016, its #2810 holding.
  • Russell Frank Company first reported a position in Acceleron Pharma in Q4 2013 and has held it in 2 quarters since.
  • Russell Frank Company's Acceleron Pharma position peaked at $840K in Q4 2013.
  • 128 funds tracked by Wall St. Rank held Acceleron Pharma as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.